Palbociclib 125 mg (Palbonix): A Targeted Therapy for Breast Cancer

(4 customer reviews)

Generic Name: Palbociclib

Manufacturer:  Beacon Pharma

Capsule: 21’s Pot

Originator: Ibrance by Pfizer

Contact For Order:

WhatsApp & WeChat: +8801965692534

Email: luckycapsulesbd@gmail.com

WeChat QR Code

Categories: ,

Palbociclib 125 mg (Palbonix) is a targeted therapy used in combination with letrozole to treat advanced breast cancer. Learn about its benefits and potential side effects here.

What is Palbociclib 125 mg?

  • Palbociclib 125 mg is an oral medication used in the treatment of breast cancer in postmenopausal women.
  • It works by inhibiting two proteins, CDK4 and CDK6, that play a role in the growth and division of cancer cells.
  • This medication is prescribed as a combination therapy with another drug called letrozole, which is an aromatase inhibitor.
  • Palbociclib 125mg is a prescription-only medication and should only be taken under the guidance of a healthcare professional.

How does Palbociclib 125 mg help treat breast cancer?

  • Palbociclib 125mg is a targeted therapy that specifically works on the proteins that drive cancer cell growth.
  • It is used in combination with letrozole, which helps to lower the levels of estrogen in the body.
  • This combination therapy has been shown to significantly improve progression-free survival in women with HR-positive, HER2-negative advanced breast cancer.
  • Palbociclib 125 mg can also help delay the need for chemotherapy, which can have more severe side effects.

What are the benefits and potential side effects of Palbociclib 125 mg?

  • Palbociclib 125mg has been shown to significantly improve progression-free survival in women with advanced breast cancer.
  • This medication is generally well-tolerated, but some common side effects may include fatigue, nausea, decreased appetite, and hair loss.
  • More serious side effects may include low white blood cell counts, which can increase the risk of infection and blood clots.
  • Your healthcare provider will monitor your blood counts regularly while you are taking Palbociclib 125mg to ensure that it is safe for you to continue the medication.

Proper Storage of Palbociclib 125 mg

  • Palbociclib 125mg should be stored at room temperature, between 68°F and 77°F (20°C and 25°C).
  • Keep the medication in its original container, tightly closed, and away from moisture and heat.
  • Do not store Palbociclib 125mg in the bathroom or any other humid place.
  • Keep the medication out of reach of children and pets.
  • When traveling with Palbociclib 125 mg, make sure to keep it in a cool, dry place.
  • If you are using a pill dispenser, make sure it is clean and dry before putting the medication in it.
  • Check the expiration date on the medication regularly and dispose of any expired pills properly.
  • If you have any questions about how to store Palbociclib 125mg, ask your healthcare provider or pharmacist.

4 reviews for Palbociclib 125 mg (Palbonix): A Targeted Therapy for Breast Cancer

  1. Steve Olson

    Very easy order process. Price was excellent and their follow up on the shipping all the way to delivery was great!!

  2. Mhd Bel

    I highly recommend this seller, very fast service for a reasonable price. Thank you

  3. ІРИНА ШЕРЕМЕТ

    Thank you very much for Palbociclib and the support of the order, I ordered my mother to Ukraine during the war through Poland, there were many nuances, but the managers were always in touch and helped with all the documents that the customs wanted, Palbociclib got through, passed the originality test.
    Thank you 🙏 for the opportunity to receive treatment with affordable drugs!

  4. Huilin Li

    I bought Palbonix from lucky capsules. During the processes the staffs of lucky capsules supplied remarkable services to me, which made everything much easier. Now I have got the Palbonix and checked them. All Palbonix passed the “Authenticity control of Beacon products”. Really appreciate the help from lucky capsules!

Add a review

Your email address will not be published. Required fields are marked *